Littlejohn & Co’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Littlejohn & Co’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$196K	–	123
2022 Q2	$196K	Hold	20,000	–	–	0.07%	75
2022 Q1	$196K	Hold	20,000	–	–	0.05%	86
2021 Q4	$194K	Hold	20,000	–	–	0.05%	86
2021 Q3	$195K	Hold	20,000	–	–	0.06%	105
2021 Q2	$193K	Buy	+20,000	New	+$195K	0.06%	121

Other funds holding MSAC

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Littlejohn & Co's MSAC Position: Q3 2022 in Review

Littlejohn & Co sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q3 2022, closing a stake of 20,000 shares — an estimated $196K sold.

Littlejohn & Co first reported a position in MSAC in Q2 2021 and held it in 5 quarters. The position peaked at $196K in Q2 2022. 53 funds tracked by Wall St. Rank hold MSAC as of Q3 2022.

Littlejohn & Co reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
Littlejohn & Co sold 20,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q3 2022, an estimated $196K.
Littlejohn & Co first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 5 quarters.
Littlejohn & Co's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $196K in Q2 2022.
53 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q3 2022.

Based on Littlejohn & Co's 13F filing for Q3 2022, filed 14 Nov 2022.